Pressure Biosciences Announces A Letter Of Intent To Purchase SkinScience Labs

Pressure Biosciences, a leader of pressure-based instruments, cosmeceuticals, biotherapeutics, biotechnology, food & beverage, has made on Thursday April 30, 2020 that the announcement of letter to acquire the SkinScience Labs, Inc, which is a parent company of Dr. Denese Anti-Aging and skin care product lines.

According to the details released by the PR Newswire News Agency, the company has also announced the plans to acquire Cannaworx on April 28, 2020. Dr. Denese is an global leader in scientific skin care remedies through technologies. Dr. Denese has also created the award winning Dr. Denese SkinScience. All the skin line, skin care and aging products of Dr. Denese have been the top seller over the past 17 years.

Chief Executive Officer and President PBI, Mr. Richard Schumacher said, “The Dr. Denese SkinScience brand has reached the top performing status on QVC for a skin care line, selling over 25 million units and receiving multiple QVC customer choice beauty awards.”

“Adrienne’s tremendous brand recognition, regularly repeating customer base, and major existing sales momentum brings immediate accretive impact into the PBI portfolio – and we know that our UST nanoemulsions will create powerful new leverage and opportunities for her expanding product lines. Our team has worked very hard to bring this pivotal transition together for PBI and its shareholders, and we are very excited about the prospects for growth and value appreciation in our combined companies going forward,” Mr. Schumacher further added.

Partner of Dr. Denese to Create Cannaworx, Dr. Bobby Ghalil said, “We are very proud to have a luminary like Dr. Denese bringing her vision and dedication to breakthrough innovations and quality in skin care and anti-aging products, and her large and loyal following of dedicated customers into our new, combined company.”

Leave a Reply

Your email address will not be published. Required fields are marked *